Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,211,967
+$9,970,476 QoQ
Shares Held
245,246
+127.6% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
3.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
15 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Derivatives in BBIO
reported options exposure · as of Sep 30, 2025CallValue
$6,752,200
CallShares
130,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SPHERA FUNDS MANAGEMENT LTD. holds $325,221,568 across 61 Biotechnology names. BBIO ranks #2 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
|
1,339,971 | $36,299,814 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
This page
|
245,246 | $18,211,967 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
809,333 | $16,955,526 | |
| 4 | SNDX |
Syndax Pharmaceuticals Inc
|
724,563 | $16,925,791 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
416,340 | $16,024,926 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
603,377 | $8,724,831 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
214,914 | $8,645,990 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
139,900 | $7,902,951 |
All Filings in BBIO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,211,967 | 245,246 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,241,491 | 107,746 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,116,347 | 40,746 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $6,752,200 | 130,000 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $2,154,682 | 49,900 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $3,761,323 | 87,108 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,673,638 | 366,608 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $24,840,855 | 905,279 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $21,453,716 | 842,644 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $23,052,073 | 910,070 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $5,182,518 | 204,600 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $18,117,759 | 585,956 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $1,546,000 | 50,000 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $11,390,234 | 282,146 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $9,111,810 | 345,537 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,532,122 | 321,635 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $2,236,000 | 130,000 | Call | Defined | 2023-08-14 | |
| 2023-03-31 | $9,317,678 | 561,983 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $3,316,000 | 200,000 | Call | Defined | 2023-05-15 | |
| 2021-03-31 | $1,471,624 | 23,890 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,228,269 | 157,900 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||